D.A. Crosby

Dr. D.A. Crosby


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Human Reproduction
Verified
Journal Article
Open access
PDF file
DCD.A. Crosby
D.A. Crosby
LGL E Glover
L E Glover
EBE P Brennan
E P Brennan
PKP Kelly
P Kelly
PCP Cormican
P Cormican
DBD J Brennan
D J Brennan
Which transcriptomic alterations in mid-luteal endometrial scratch biopsies, taken prior to the assisted reproductive treatment (ART) treatment cycle are associated with unsuccessful pregnancy? Dysregulated interleukin-17 (IL-17) pathway components are demonstrated in women who fail to become pregnant after ART. Implantation failure is now recognised as a critical factor in unexplained infertility and may be an important component of failed ART. Using a prospective longitudinal study design, 29 nulliparous women with unexplained infertility undergoing ART were recruited between October 2016 and February 2018. Mid-luteal stage endometrium and matched serum samples were collected, and patients underwent a single embryo transfer in the subsequent cycle. RNA-seq analysis of endometrial biopsies was performed on the discovery cohort (n = 20). Gene set enrichment analysis of the differentially expressed genes (DEGs) was performed. Endometrium and serum were then prepared for IL-17A analysis by ELISA. There were 204 differentially expressed protein-coding genes identified in tissue from women who became pregnant (n = 9) compared with tissue from women who failed to become pregnant (n = 11) (false discovery rate; P < 0.05). Of the 204 DEGs, 166 were decreased while 38 were increased in the pregnant compared to the non-pregnant groups. Gene set enrichment analysis of the DEGs identified an over-representation of IL-17 and Pl3K-Akt signalling pathways. All the DEGs within the IL-17 signalling pathway (MMP3, MMP1, IL1β, LCN2, S100A9 and FOSL1) demonstrated decreased expression in the pregnant group. Serum IL-17 protein levels were increased in the non-pregnant discovery cohort (n = 11) and these findings were confirmed a validation cohort (n = 9). Limitations of our study include the cohort size and the lack of aneuploidy data for the embryos; however, all embryos transferred were single good or top-quality blastocysts. These findings demonstrate dysregulated IL-17 pathway components in women who fail to become pregnant after ART. Elevated serum levels of the pro-inflammatory cytokine IL-17 may predict failure of ART in women with unexplained infertility. Future trials of anti-IL-17 therapies in this cohort warrant further investigation. Funding from the UCD Wellcome Institutional Strategic Support Fund, which was financed jointly by University College Dublin and the SFI-HRB-Wellcome Biomedical Research Partnership (ref 204844/Z/16/Z), is acknowledged. The authors have no competing interests. NA.

21 December 2017 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
DCD.A. Crosby
D.A. Crosby
COClaire O’rEilly
Claire O’rEilly
HMHelen McHale
Helen McHale
FMFionnuala M. McAuliffe
Fionnuala M. McAuliffe
RMRhona Mahony
Rhona Mahony

1 May 2019 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
DCD.A. Crosby
D.A. Crosby
MMMartina M. Murphy
Martina M. Murphy
RSRicardo Segurado
Ricardo Segurado
FBFionnuala Byrne
Fionnuala Byrne
RMRhona Mahony
Rhona Mahony
FMFionnuala M. McAuliffe
Fionnuala M. McAuliffe

19 June 2024 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
SPSarah Petch
Sarah Petch
DCD.A. Crosby
D.A. Crosby

17 September 2018 in Human Fertility
Verified
Journal Article
Closed access
DCD.A. Crosby
D.A. Crosby
YOYvonne O’brien
Yvonne O’brien
LGLouise Glover
Louise Glover
FMFiona Martyn
Fiona Martyn
MWMary Wingfield
Mary Wingfield
To date there is limited published data assessing whether body mass index (BMI) influences endometrial thickness (ET) and whether this impacts on pregnancy outcomes in single blastocyst FET cycles. The objective of this study, therefore, was to examine the relationship between BMI and ET on the outcome of single blastocyst FET cycles over a five-year period from 2012 until 2016. Patient age, BMI, endometrial pattern and ET prior to FET were recorded. Pregnancy outcomes included: implantation rate, clinical pregnancy rate and live birth rate. A total of 464 cycles met the inclusion criteria and the female age was 36.0 ± 3.0 years (mean ± SD). The mean ± SD BMI was 23.3 ± 3.1 kg/m2 and median ± SD ET was 8.1 ± 1.5 mm. BMI and ET were modestly correlated (Pearson r = 0.244) and there was an association between higher BMI category and higher median ET (7.2, 8.0, 8.3, 8.9 mm; p < 0.001). However, there was no association between ET and pregnancy outcome, either unadjusted, or adjusted for BMI, age, endometrial pattern or embryo quality. The data suggests that although ET increases with increasing BMI, there are no differences in cycle outcome. Importantly, this implies that an ET <8 mm may not jeopardize pregnancy outcome in women with lower BMI. The development of a norm referenced test for BMI and ET may prove to be a helpful adjunct in the clinical IVF setting.

18 October 2016 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
DCD.A. Crosby
D.A. Crosby
JMJan Miletin
Jan Miletin
JSJana Semberova
Jana Semberova
SDSean Daly
Sean Daly